Who owns Milestone Pharmaceuticals Inc.?
Prices and market caps: Cboe delayed data, at least 15 minutes delayed. Not real-time. Fundamentals from SEC filings.
Institutional ownership of MIST from SEC Form 13F filings across 57 reporting managers. All positions are from one synchronized reporting period — 2026-06-30 books, filed up to 45 days after quarter end — so every row is comparable.
As of the 2026-06-30 reporting period, 57 institutions disclosed 30.4M shares of Milestone Pharmaceuticals Inc. worth $40.7M — about 23.3% of shares outstanding; the largest disclosed holder is Pavaki Capital Management LLC. Source: SEC Form 13F filings, parsed by EvidInvest.
57
13F holders
$40.7M
value, 2026 filers
23.3%
of shares outstanding (30.4M sh)
6
new positions (2026 filers)
Top institutional holders
ordered by shares owned · positions as of 2026-06-30· % of fund = share of the manager's own book · % of co. = share of MIST's shares outstanding
| # | Manager | Shares | Value | % of fund | % of co. | Δ shares QoQ |
|---|---|---|---|---|---|---|
| 1 | Pavaki Capital Management LLCNEW | 9.1M | $12.2M | 4.2% | 7% | new |
| 2 | Point72 Asset Management, L.P. | 5.4M | $7.3M | 0.0% | 4.2% | +398.4% |
| 3 | Simplify Asset Management Inc. | 3.3M | $4.5M | 0.1% | 2.6% | +122.3% |
| 4 | MILLENNIUM MANAGEMENT LLC | 3.1M | $4.2M | 0.0% | 2.4% | +103.5% |
| 5 | TWO SIGMA INVESTMENTS, LP | 2.0M | $2.7M | 0.0% | 1.6% | -12.0% |
| 6 | MARSHALL WACE, LLP | 1.8M | $2.4M | 0.0% | 1.4% | -7.6% |
| 7 | TORONTO DOMINION BANK | 750,000 | $1.0M | 0.0% | 0.6% | 0.0% |
| 8 | AMERIPRISE FINANCIAL INCNEW | 666,666 | $893,332 | 0.0% | 0.5% | new |
| 9 | MORGAN STANLEY | 635,211 | $851,183 | 0.0% | 0.5% | -12.3% |
| 10 | UBS Group AG | 465,403 | $623,641 | 0.0% | 0.4% | -6.0% |
| 11 | BOOTHBAY FUND MANAGEMENT, LLC | 462,669 | $619,976 | 0.0% | 0.4% | +174.3% |
| 12 | SUSQUEHANNA INTERNATIONAL GROUP, LLP | 359,895 | $482,259 | 0.0% | 0.3% | -30.7% |
| 13 | Aptus Capital Advisors, LLC | 339,450 | $454,863 | 0.0% | 0.3% | +21.1% |
| 14 | Squarepoint Ops LLC | 231,824 | $310,644 | 0.0% | 0.2% | -31.2% |
| 15 | LPL Financial LLC | 220,873 | $295,970 | 0.0% | 0.2% | +14.2% |
| 16 | Balyasny Asset Management L.P. | 220,498 | $295,467 | 0.0% | 0.2% | -74.1% |
| 17 | BNP PARIBAS FINANCIAL MARKETS | 173,704 | $232,763 | 0.0% | 0.1% | -1.6% |
| 18 | Wealthspire Advisors, LLC | 140,629 | $188,443 | 0.0% | 0.1% | +1223.1% |
| 19 | Valeo Financial Advisors, LLC | 130,699 | $175,137 | 0.0% | 0.1% | 0.0% |
| 20 | Cascades Capital Asset Management, LLCNEW | 83,610 | $112,037 | 0.0% | 0.1% | new |
| 21 | JANE STREET GROUP, LLC | 57,787 | $77,435 | 0.0% | 0% | -63.8% |
| 22 | Bay Rivers Group | 46,633 | $62,488 | 0.0% | 0% | +55.9% |
| 23 | SG Americas Securities, LLC | 45,574 | $61 | 0.0% | 0% | +7.2% |
| 24 | GEODE CAPITAL MANAGEMENT, LLC | 40,789 | $54,657 | 0.0% | 0% | 0.0% |
| 25 | October Effect Ltd | 40,000 | $53,600 | 0.1% | 0% | -23.0% |
Source: SEC Form 13F-HR filings (institutional managers over $100M in US-listed positions). 13Fs disclose long positions only, up to 45 days after quarter end; each manager's latest filed quarter is shown per row and dollar values are the manager's filed marks. Aggregates labeled "2026 filers" count only managers whose latest book is a 2026 quarter. Related: valuation · options positioning · supply chain. Research, not investment advice.